Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion type Assertion NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_head.
- NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion description "[Particularly, the sustained activation of epidermal growth factor receptor (EGFR), hedgehog, Wnt/?-catenin, Notch, hyaluronan (HA)/CD44 and stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) during the epithelial-mesenchymal transition (EMT) process may provide critical functions for PC progression to locally invasive, metastatic and androgen-independent disease states and treatment resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_provenance.
- NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion evidence source_evidence_literature NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_provenance.
- NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion SIO_000772 21607288 NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_provenance.
- NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion wasDerivedFrom befree-20140225 NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_provenance.
- NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_assertion wasGeneratedBy ECO_0000203 NP162092.RAMAyMx5Ck9l4I27fQyr75YxuOi8X7H6vb_q3vsTf7SnU130_provenance.